RaymondJHutchinsonMD

Pediatric Hematology & Oncology • Ann Arbor, MI

Pediatric Hematologic Oncology

Active Emeritus Professor of Pediatrics, University of Michigan Medical School

Join to view full profile

Dr. Hutchinson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hutchinson's full profile

Already have an account?

Office
1500 E Medical Center Dr
# 7
Ann Arbor, MI 48109
Phone+1 734-936-9814

Education & Training

University of MichiganMS, Clinical trial design and statistical analysis, 1988 - 1989
Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1975 - 1978
Tufts Medical CenterResidency, Pediatrics, 1973 - 1975
Harvard Medical SchoolClass of 1973

Certifications & Licensure

MI State Medical License 1978 - 2027
PA State Medical License 1975 - 1978
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma Start of enrollment: 2003 Mar 01
Terminated
Phase 2
Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma Start of enrollment: 2001 Apr 01
Completed
Phase 2
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer Start of enrollment: 2003 Oct 13
Completed
Study of Kidney Tumors in Younger Patients Start of enrollment: 2006 Feb 27
Recruiting
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma Start of enrollment: 1999 Mar 15
Completed
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
Terminated
Phase 1, Phase 2
Childhood Cancer Survivor Study Start of enrollment: 1995 Jan 05
Recruiting
Roles: Principal Investigator, Contact
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma Start of enrollment: 2010 Aug 09
Active, not recruiting
Phase 3
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies Start of enrollment: 2011 Mar 01
Completed
Phase 1
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum Start of enrollment: 2012 Feb 01
Join now to see all

Publications & Presentations

PubMed

Comparing internal versus external carotid artery branch delivery of intraarterial chemotherapy for the treatment of retinoblastoma.
Emily Chang, Yunshu Zhou, David Musch, Amy Edmonds, Laura Sedig
Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie. 2023-09-01
6 citations
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, John M Goldberg, Lewis B Silverman
Pediatric Blood & Cancer. 2022-11-01
11 citations
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Child...
Sarah K Tasian, Lewis B Silverman, James A Whitlock, Richard Sposto, Joseph P Loftus
Haematologica. 2022-10-01

Grant Support

Childrens Cancer GroupNational Cancer Institute1997–2002
Effect Of Recipient Age /Graft VS Host Disease Post BMTNational Institute On Aging2001
Vaccine Therapy Of Pediatric Malignancies Utilizing Dendritic CellsNational Center For Research Resources1999–2000
Treatment Of Children With Lower Risk Leukemia Incorporating 6 ThioguanineNational Center For Research Resources1998–1999
Continuous 21 Day Infusion Of Topotecan In Children With Relapsed Solid TumorsNational Center For Research Resources1997–1999
B43-PAP Immunotoxin Combined With Standard 4 Drug Induction For CD+ AllNational Center For Research Resources1997–1999
Oral And IV Navelbine (VINORELBINE) In Pediatric Cancer PatientsNational Center For Research Resources1997
Continual Mercaptopurine Followed By Continual Cytosine Arabinoside In LeukemiaNational Center For Research Resources1997
A Pilot Trial Of 6 Thioguanine In Children LeukemiaNational Center For Research Resources1997
Treatment Of Newly Diagnosed Children With Low Risk LeukemiaNational Center For Research Resources1996
CCG 0936--Oral And Intravenous Navelbine In Pediatric Cancer PatientsNational Center For Research Resources1996
CCG 0932--Temozolomide In Pediatric And Adolescent Patients With CancerNational Center For Research Resources1996
CCG 0926--All Trans Retinoic Acid In Combination With Interferon Alpha2aNational Center For Research Resources1996
Cancer In ChildrenNational Cancer Institute1994–1996
Children'S Cancer Study GroupNational Cancer Institute1988–1993